Homocysteine, the cholesterol of the 21st century. Impact of hyperhomocysteinemia on patency and amputation-free survival after intervention for critical limb ischemia.

Hdl Handle:
http://hdl.handle.net/10147/304782
Title:
Homocysteine, the cholesterol of the 21st century. Impact of hyperhomocysteinemia on patency and amputation-free survival after intervention for critical limb ischemia.
Authors:
Heneghan, Helen M; Sultan, Sherif
Affiliation:
Western Vascular Institute, Department of Vascular & Endovascular Surgery, University College Hospital, Galway, Ireland.
Citation:
Homocysteine, the cholesterol of the 21st century. Impact of hyperhomocysteinemia on patency and amputation-free survival after intervention for critical limb ischemia. 2008, 15 (4):399-407 J. Endovasc. Ther.
Publisher:
Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists
Journal:
Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists
Issue Date:
Aug-2008
URI:
http://hdl.handle.net/10147/304782
DOI:
10.1583/08-2385.1
PubMed ID:
18729558
Abstract:
To assess the prevalence of hyperhomocysteinemia and determine any correlation to the clinical and technical outcome of peripheral arterial revascularization for critical limb ischemia (CLI).
Item Type:
Article
Language:
en
MeSH:
Aged; Aged, 80 and over; Amputation; Chi-Square Distribution; Female; Humans; Hyperhomocysteinemia; Ischemia; Leg; Limb Salvage; Logistic Models; Male; Middle Aged; Peripheral Vascular Diseases; Prevalence; Retrospective Studies; Risk Factors; Survival Analysis; Vascular Patency
ISSN:
1526-6028

Full metadata record

DC FieldValue Language
dc.contributor.authorHeneghan, Helen Men_GB
dc.contributor.authorSultan, Sherifen_GB
dc.date.accessioned2013-10-30T14:22:23Z-
dc.date.available2013-10-30T14:22:23Z-
dc.date.issued2008-08-
dc.identifier.citationHomocysteine, the cholesterol of the 21st century. Impact of hyperhomocysteinemia on patency and amputation-free survival after intervention for critical limb ischemia. 2008, 15 (4):399-407 J. Endovasc. Ther.en_GB
dc.identifier.issn1526-6028-
dc.identifier.pmid18729558-
dc.identifier.doi10.1583/08-2385.1-
dc.identifier.urihttp://hdl.handle.net/10147/304782-
dc.description.abstractTo assess the prevalence of hyperhomocysteinemia and determine any correlation to the clinical and technical outcome of peripheral arterial revascularization for critical limb ischemia (CLI).en_GB
dc.language.isoenen
dc.publisherJournal of endovascular therapy : an official journal of the International Society of Endovascular Specialistsen_GB
dc.rightsArchived with thanks to Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialistsen_GB
dc.subject.meshAged-
dc.subject.meshAged, 80 and over-
dc.subject.meshAmputation-
dc.subject.meshChi-Square Distribution-
dc.subject.meshFemale-
dc.subject.meshHumans-
dc.subject.meshHyperhomocysteinemia-
dc.subject.meshIschemia-
dc.subject.meshLeg-
dc.subject.meshLimb Salvage-
dc.subject.meshLogistic Models-
dc.subject.meshMale-
dc.subject.meshMiddle Aged-
dc.subject.meshPeripheral Vascular Diseases-
dc.subject.meshPrevalence-
dc.subject.meshRetrospective Studies-
dc.subject.meshRisk Factors-
dc.subject.meshSurvival Analysis-
dc.subject.meshVascular Patency-
dc.titleHomocysteine, the cholesterol of the 21st century. Impact of hyperhomocysteinemia on patency and amputation-free survival after intervention for critical limb ischemia.en_GB
dc.typeArticleen
dc.contributor.departmentWestern Vascular Institute, Department of Vascular & Endovascular Surgery, University College Hospital, Galway, Ireland.en_GB
dc.identifier.journalJournal of endovascular therapy : an official journal of the International Society of Endovascular Specialistsen_GB
dc.description.fundingNo fundingen
dc.description.provinceConnachten
dc.description.peer-reviewpeer-reviewen

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.